1. A multimodal, multi-cancer detection assay designed to enable screening and subsequent monitoring across diverse cancer types using liquid biopsy samples.
2. Insights gained from multi-institutional clinical studies evaluating G2M Oncology and Prenatal Assay performance across diverse populations.
3. A strategic roadmap toward an emerging liquid biopsy–based multi-cancer detection assay utilizing mutation and methylation biomarkers for early diagnosis
